JP2019108328 NOVEL VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES

Settings

Stemming

Single Family Member

Include NPL

Feedback

Goto Application

Office

Japan

Application Number 2019015717

Application Date 31.01.2019

Publication Number 2019108328

Publication Date 04.07.2019

Publication Kind A

IPC

CPC

View more classifications

View less classifications

Applicants ZOETIS SERVICES LLC
ゾエティス・サービシーズ・エルエルシー

Inventors PAUL JOSEPH DOMINOWSKI
ドミノウスキー，ポール・ジョゼフ
SHARATH K RAI
ライ，シャラス・ケイ
LAUREL MARY SLY
スライ，ローレル・メアリー
COREY PATRICK COOK
クック，コーリー・パトリック
DUNCAN MWANGI
ムワンギ，ダンカン
DENNIS L FOSS
フォス，デニス・エル
KREBS RICHARD LEE
クレブス，リチャード・リー

Agents 小野　新次郎
山本　修
宮前　徹
中西　基晴
泉谷　玲子

Priority Data 61/823,189 14.05.2013 US

Title

(EN) NOVEL VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES

(JA) 免疫刺激性オリゴヌクレオチドを含む新規のワクチン組成物

Abstract

(EN)

PROBLEM TO BE SOLVED: To provide a vaccine composition comprising an antigen component and an adjuvant component.

SOLUTION: The adjuvant component comprises a P-class immunostimulatory oligonucleotide and either a combination of a saponin and a sterol, or an oily phase comprising an oil and optionally one or more emulsifiers. The oily phase comprises 2-20 v/v% of the vaccine composition, where the antigen component is an EHV antigen or a Leishmania antigen.

SELECTED DRAWING: None

(JA)

【課題】抗原成分及びアジュバント成分を含むワクチン組成物の提供。
【解決手段】アジュバント成分は、Ｐクラス免疫刺激性オリゴヌクレオチド、ならびに、サポニン及びステロールの組み合わせ、または油、及び任意に、１つ以上の乳化剤を含む油相、のいずれかを含み、油相がワクチン組成物の２〜２０ｖ／ｖ％を構成し、抗原成分が、ＥＨＶ抗原またはリーシュマニア抗原である、ワクチン組成物。
【選択図】なし

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
39	characterised by the immunostimulating additives, e.g. chemical adjuvants

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
002	Protozoa antigens
008	Leishmania antigens

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
12	Viral antigens

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
12	Viral antigens
245	Herpetoviridae, e.g. herpes simplex virus
27	Equine rhinopneumonitis virus

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31	Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12	Antivirals
20	for DNA viruses
22	for herpes viruses

Processing

National Phase Entries

Authority File

Settings

Feedback

Goto Application

1. JP2019108328 - NOVEL VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES

C	CHEMISTRY; METALLURGY
12	BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N	MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2710	dsDNA Viruses
00011	dsDNA Viruses
16011	Herpesviridae
16034	Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein